Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
作者信息
Araf Shamzah, Korfi Koorosh, Bewicke-Copley Findlay, Wang Jun, Cogliatti Sergio, Kumar Emil, Forrer Flavio, Barrington Sally F, Graham Trevor A, Scott David W, Rimsza Lisa M, Davies Andrew, Johnson Peter, Okosun Jessica, Fitzgibbon Jude, Fehr Martin
机构信息
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
出版信息
Haematologica. 2020 Jun;105(6):318-321. doi: 10.3324/haematol.2019.242206. Epub 2020 Apr 9.
Abstract
摘要
相似文献
1
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
Haematologica. 2020 Jun;105(6):318-321. doi: 10.3324/haematol.2019.242206. Epub 2020 Apr 9.
2
Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
PET Clin. 2014 Oct;9(4):443-55, vi. doi: 10.1016/j.cpet.2014.06.001. Epub 2014 Jul 30.
3
Extranodal involvement of multiple organs in diffuse large B cell lymphoma detected on F-FDG PET/CT.
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):734-735. doi: 10.1007/s00259-019-04666-0. Epub 2020 Jan 8.
4
The Central Cavitation in Pulmonary Diffuse Large B-Cell Lymphoma Detected by 18F-FDG PET/CT.
Clin Nucl Med. 2022 Jun 1;47(6):562-563. doi: 10.1097/RLU.0000000000004173. Epub 2022 Apr 19.
5
Primary diffuse large B-cell lymphoma of seminal vesicles detected by F-FDG PET/CT.
Hell J Nucl Med. 2021 May-Aug;24(2):163-164. doi: 10.1967/s002449912360. Epub 2021 Aug 6.
6
An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT.
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):218-219. doi: 10.1007/s00259-019-04428-y. Epub 2019 Jul 25.
7
Searing abdomen: Infrequent presentation of peritoneal lymphomatosis in Diffuse Large B-Cell Lymphoma on 18F-FDG PET-CT scan.
J Pak Med Assoc. 2022 Aug;72(8):1670-1671. doi: 10.47391/JPMA.22-89.
8
18F-FDG PET/CT demonstrated symmetric FDG uptake in internal capsule in a diffuse large B cell lymphoma patient with false interpretation on multiparametric brain MRI.
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2923-2924. doi: 10.1007/s00259-020-04737-7. Epub 2020 Mar 4.
9
The value of 18F-FDG PET/CT in evaluating the efficacy of chemotherapy for diffuse large B-cell lymphoma with cardiac involvement.
J Nucl Cardiol. 2022 Dec;29(6):3548-3553. doi: 10.1007/s12350-021-02551-8. Epub 2021 Mar 3.
10
A rare case of Diffuse Large B-Cell Lymphoma of the Prostate on 18F-FDG PET-CT.
J Pak Med Assoc. 2021 Jan;71(1(B)):388-389.
引用本文的文献
1
Prognostic value of genetic alterations and F-FDG PET/CT imaging features in diffuse large B cell lymphoma.
Am J Cancer Res. 2023 Feb 15;13(2):509-525. eCollection 2023.
2
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.
Blood Adv. 2023 Mar 14;7(5):845-855. doi: 10.1182/bloodadvances.2022007536.
3
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.
Blood Adv. 2022 Feb 8;6(3):1025-1037. doi: 10.1182/bloodadvances.2021005954.
4
Radiomic Features of F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes.
Contrast Media Mol Imaging. 2021 Nov 22;2021:6347404. doi: 10.1155/2021/6347404. eCollection 2021.
本文引用的文献
1
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Lancet Oncol. 2019 May;20(5):649-662. doi: 10.1016/S1470-2045(18)30935-5. Epub 2019 Apr 1.
2
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Blood Cancer J. 2018 Aug 1;8(8):74. doi: 10.1038/s41408-018-0111-6.
3
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant.
Haematologica. 2019 Apr;104(4):e174-e177. doi: 10.3324/haematol.2018.196907. Epub 2018 Jul 5.
4
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Nat Med. 2018 May;24(5):679-690. doi: 10.1038/s41591-018-0016-8. Epub 2018 Apr 30.
5
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.
6
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.
Leukemia. 2018 May;32(5):1261-1265. doi: 10.1038/s41375-018-0043-y. Epub 2018 Feb 8.
7
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.
8
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Blood. 2017 Oct 19;130(16):1800-1808. doi: 10.1182/blood-2017-03-769620. Epub 2017 Aug 3.
9
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
Cell. 2017 Feb 9;168(4):613-628. doi: 10.1016/j.cell.2017.01.018.
10
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis.
Leukemia. 2016 Dec;30(12):2385-2395. doi: 10.1038/leu.2016.135. Epub 2016 May 20.
Zotero 插件